Toshio Matsumoto

Toshio Matsumoto

Auto-generated profile, based on publicly available information

Toshio Matsumoto

University of Tokushima, Tokushima, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

15 October 2020 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
TMToshio Matsumoto
Toshio Matsumoto
IEItsuro Endo
Itsuro Endo

23 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
BDBingzi Dong
Bingzi Dong
MHMasahiro Hiasa
Masahiro Hiasa
YHYoshiki Higa
Yoshiki Higa
YOYukiyo Ohnishi
Yukiyo Ohnishi
IEItsuro Endo
Itsuro Endo
TMToshio Matsumoto
Toshio Matsumoto
Exercise results in mechanical loading of the bone and stimulates energy expenditure in the adipose tissue. It is therefore likely that the bone secretes factors to communicate with adipose tissue in response to mechanical loading. Interleukin (IL)−11 is known to be expressed in the bone, it is upregulated by mechanical loading, enhances osteogenesis and suppresses adipogenesis. Here, we show that systemic IL-11 deletion (IL-11−/−) results in reduced bone mass, suppressed bone formation response to mechanical loading, enhanced expression of Wnt inhibitors, and suppressed Wnt signaling. At the same time, the enhancement of bone resorption by mechanical unloading was unaffected. Unexpectedly, IL-11−/− mice have increased systemic adiposity and glucose intolerance. Osteoblast/osteocyte-specific IL-11 deletion in osteocalcin-Cre;IL-11fl/fl mice have reduced serum IL-11 levels, blunted bone formation under mechanical loading, and increased systemic adiposity similar to IL-11−/− mice. Adipocyte-specific IL-11 deletion in adiponectin-Cre;IL-11fl/fl did not exhibit any abnormalities. We demonstrate that osteoblast/osteocyte-derived IL-11 controls both osteogenesis and systemic adiposity in response to mechanical loading, an important insight for our understanding of osteoporosis and metabolic syndromes.

2 July 2013 in Circulation
Verified
Journal Article
Closed access
PDF file
SYSumiko Yoshida
Sumiko Yoshida
Ken-ichi AiharaKen-ichi Aihara
Ken-ichi Aihara
Yasumasa IkedaYasumasa Ikeda
Yasumasa Ikeda
YSYuka Sumitomo-Ueda
Yuka Sumitomo-Ueda
RURyoko Uemoto
Ryoko Uemoto
TMToshio Matsumoto
Toshio Matsumoto
Background—: Hypoandrogenemia is associated with an increased risk of ischemic diseases. Because actions of androgens are exerted through androgen receptor (AR) activation, we studied hind-limb ischemia in AR knockout mice to elucidate the role of AR in response to ischemia. Methods and Results—: Both male and female AR knockout mice exhibited impaired blood flow recovery, more cellular apoptosis, and a higher incidence of autoamputation after ischemia. In ex vivo and in vivo angiogenesis studies, AR-deficient vascular endothelial cells showed reduced angiogenic capability. In ischemic limbs of AR knockout mice, reductions in the phosphorylation of the Akt protein kinase and endothelial nitric oxide synthase were observed despite a robust increase in hypoxia-inducible factor 1α and vascular endothelial cell growth factor ( VEGF ) gene expression. In in vitro studies, siRNA-mediated ablation of AR in vascular endothelial cells blunted VEGF-stimulated phosphorylation of Akt and endothelial nitric oxide synthase. Immunoprecipitation experiments documented an association between AR and kinase insert domain protein receptor that promoted the recruitment of downstream signaling components. Conclusions—: These results document a physiological role of AR in sex-independent angiogenic potency and provide evidence of novel cross-talk between the androgen/AR signaling and VEGF/kinase insert domain protein receptor signaling pathways.

1 February 2019 in Internal Medicine
Verified
Journal Article
Open access
PDF file
MTMakio Takahashi
Makio Takahashi
HTHayato Tabu
Hayato Tabu
AOAkihiko Ozaki
Akihiko Ozaki
THToshiaki Hamano
Toshiaki Hamano
TTTakao Takeshima
Takao Takeshima
FGfor the REBORN study group
for the REBORN study group
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 September 1997 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
RORyo Okazaki
Ryo Okazaki
YTYasuo Totsuka
Yasuo Totsuka
KHKumiko Hamano
Kumiko Hamano
MAMiho Ajima
Miho Ajima
MMMasakazu Miura
Masakazu Miura
TMToshio Matsumoto
Toshio Matsumoto
Patients with poorly controlled noninsulin dependent diabetes mellitus (NIDDM) are shown to have higher bone mass. However, the influence of changes in glycemic control on bone turnover is not known. To clarify whether metabolic improvement of poorly controlled NIDDM affects bone turnover, markers for glucose, mineral, and bone metabolism were assessed before and after glycemic control for 3 weeks in 78 poorly controlled NIDDM patients with initial hemoglobin A1c over 8%. Metabolic improvement caused a reduction in urinary calcium (Ca) and phosphate (Pi) and serum 1,25(OH)2D levels, and an increase in serum Pi without changes in serum Ca or parathyroid hormone levels. Bone resorption markers, urinary deoxypyridinoline (Dpd) and type I collagen carboxy-terminal telopeptide (CTx), as well as a bone formation marker, serum bone type alkaline phosphatase (BALP), were reduced. However, another bone formation marker, serum osteocalcin (OC), was low before treatment and was elevated after treatment. The decrease in Dpd, CTx and BALP, but not the increase in OC, correlated with each other and with the improvement in glycemic indices. In conclusion, metabolic improvement of poorly controlled NIDDM decreases bone turnover within a short period. Thus, glycemic control may protect NIDDM patients from bone loss. It is possible that serum OC is affected by hyperglycemia per se, and may not correctly reflect bone turnover.